This biotech company has something cooking
Updated
There is not much time left before there's a big move higher...
Comment
Playing out exactly as anticipated. Prepare longs in purple.Trade active
I am long a VERY SMALL position at 3.60. To put it into perspective, if the stock's value goes down 50% from 3.60 I will only lose .3% of total capital traded. I will buy more if purple is reached.Comment
Added to the position. Max loss is now 1% of capital.Comment
Major breakout we've been waiting for could be coming very soon. If price breaks tomorrow it will confirm a serious trend higher.Comment
Comment
Last week was the first weekly break above blue rectangle after three failed attempts in nearly 5 years. This week confirms a monthly breakout above a $7 close. Long from mid 3s, 4s and high 6's. Will add another layer this week on a monthly confirmation, and a final layer on a possible retest of the monthly (February - which will be this week).Comment
As stated in the comment above, "Will add another layer this week on a monthly confirmation, and a final layer on a possible retest of the monthly (February - which will be this week)." The time is now. I will buy a FULL position rather than adding because I took profits at 7.70. A full position for me is 1% of capital. I may elect to increase risk depending on the DAILY price action on Monday - Thursday. I am willing to take 2% of capital risk on this trade.Comment
Price hit minimum target today of 10.50 (where blue projection ends. Possible we see resistance here.) This has been a huge winner.Trade closed: target reached
Closed 1/3rd of the position at 12.50 and 12.45. Will trail 1/2 of the remaining position (.33%), and maintain the ~$13.40 target for the 1/2 of the remaining position (.33%). Congrats longs.Comment
Took all profit at $11.10. I will re-enter a small position at 8.45. I want to see how the price action trades in the gap to return to half of my original position. Trade active
Went short at the market close on FridayRed is stop.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.